RUTW250110P1920000
- 0.00
- 0.000.00%
Russell 2000 Index Newsroom
KB Home, Lennar Upgraded at RBC Capital on Valuation, Balanced Risk/reward
Disney-Fox-Warner Trio to Disband Venu Sports in Wake of Legal Settlement With Fubo
Quanterix Shares Are Trading Lower After the Company Announced It Has Agreed to Acquire Akoya Biosciences in an All-stock Transaction.
Take-Two, Xometry: JPMorgan's Bets On Gaming, Manufacturing In 2025
BMO Capital Maintains Outperform on Intellia Therapeutics, Lowers Price Target to $50
Intellia Therapeutics Analyst Ratings
Watching TransMedics Shares, Scorpion Capital Publishes Report On Co. With $0 PT
Pacira Biosciences Shares Are Trading Higher After the Company Reported a Preliminary Year-over-year Increase in FY25 Revenue.
Turning Point Brands Analyst Ratings
Mercury General Anticipates Wildfire Losses In Southern California To Surpass $150M Reinsurance Retention Level; Coverage Available Up To $1.29B With $101M Reinstatement Premium
Neogen Shares Are Trading Lower After the Company Issued FY25 Revenue Guidance Below Estimates.
United Natural Foods Analyst Ratings
Goosehead Insurance Announces New $300M Term Loan B and Declares A One-Time Special Dividend Of $5.91 Per Share
Mersana Therapeutics Shares Are Trading Lower. The Company Announced Initial Clinical Data From the Phase 1 Dose Escalation and Backfill Cohorts for Emiltatug Ledadotin.
Analyst Expectations For Urban Outfitters's Future
Verint Gets Top Pick Tag at Needham on 'Positive Catalysts' in 2025
HIMS Downgraded, Agilon Upgraded at Citi in 2025 Health Tech Review
Match Group, Bumble's Growth Stalls: Analyst Warns Of Challenging 2025
HC Wainwright & Co. Reiterates Buy on Compass Therapeutics, Maintains $10 Price Target
Express News | The E-mini Russell 2000 Index Futures fell by 1.4% to a three-week low after the release of the USA non-farm payroll data.